体外溶出度在达到95%以上。
目的：制备氧氟沙星中空栓并考察其体外溶出度。
OBJECTIVE:To prepare ofloxacin hollow suppository(OHS) and to observe its in vitro dissolubility.
目的：制备复方苦豆子栓剂并测定其体外溶出度。
Objective:To prepare the compound sophora alopecuroides suppository and determine its dissolution rate in vitro.
目的：建立那格列奈片的体外溶出度的测定方法。
OBJECTIVE To establish the dissolution method for nateglinide tablets.
方法按中国药典所载转蓝法进行体外溶出度测定。
METHODS According to Chinese Pharmacopoeia(2000 edition), the rotating basket method was employed.
目的应用固体分散技术，提高非洛地平的体外溶出度。
Objective To improve the solubility and dissolution of felodipine by preparing its solid dispersions.
考察了不同处方微丸的粉体学性质、收率和体外溶出度。
The micromeritic properties, reception percentage and in vitro dissolution of pellets with different spheroniser load were determined.
结论：采用溶剂沉积法提高丹参酮的体外溶出度是可行的。
Conclusion: The dissolution rate of tanshinone in vitro can be improved with solvent deposition method.
自身对照法做为银杏叶片体外溶出度测定方法操作简便可行。
It is convenient feasible by self contrast method to determine the dissolution rate of Ginkgo biloba tablets .
结果证明，采用固体分散技术能提高尼索地平的体外溶出度。
It is indicated that the solubility of Nisoldipine capsule is improved by the utilization of solid dispersion technology.
目的：探讨不同厂家加替沙星片剂与胶囊剂体外溶出度差异。
Objective: To investigate the difference of dissolution in vitro of gatifloxacin in tablet and capsule from various manufacturers.
用高效液相色谱法测定其含量，小杯法测定胶囊体外溶出度。
The tropisetron hydrochloride content was determined by HPLC, and the percentage of dissolution was evaluated.
结论优化处方的灯盏花素分散片其体外溶出度明显优于普通片。
CONCLUSION The in-vitro dissolubility of the optimized dispersed tablet is better than that of commontable.
目的：比较原研和仿制药厂生产的依巴斯汀片的体外溶出度特性。
Objective: To compare dissolution rate of first-researching and imitating Ebastine tablets in vitro.
目的制备麝香保心分散片，考察冰片和人参总皂苷的体外溶出度。
OBJECTIVE To prepare Shexiang Baoxin dispersible tablets and investigate the dissolution of borneol and total ginsenoside from them in vitro .
结果：不同厂家加替沙星片剂与胶囊剂体外溶出度存在显著差异。
Results: The differences of dissolution in vitro of gatifloxacin in tablet and capsule from various manufacturers were significant.
以体外溶出度法考察不同配比PVP共聚物胶囊的药物累积溶出度。
The accumulative dissolution rate of puerarin in coprecipitates with different ratios of puerarin-phytosomes to PVP was investigated according to dissolution release in vitro.
采用高效液相色谱法测定化橘红不同粒径粉末中柚皮苷的体外溶出度。
Results Significant differences were observed after micronization in powder characteristics, dissolution rates and concentrations of naringin, which were higher than those in the common powder.
通过FOCSDT联立方程组新解法监测了复方氯唑沙宗片体外溶出度。
Through the FOCSDT new equation group solution have monitored dissolution of compound chlorzoxazone tablets.
目的 将难溶性药物阿德福韦酯制备成固体分散体，以增加体外溶出度。
Objective To prepare adefovir dipivoxil solid dispersion from poorly-soluble adefovir dipivoxil so as to improve its dissolution rate in vitro.
方法通过不同溶剂中的溶解度实验及体外溶出度实验，筛选并优化处方。
Methods Screening the optimal formulation of liquid type carrier was carried out through measuring apparent solubility in different solvent and dissolution test in vitro.
方法：采用紫外分光光度法测定滴丸中维甲酸的含量，转篮法考察其体外溶出度。
Methods: Tretinoin in the dropping pills was determined spectrophotometrically and rotating basket method was adopted to determine its dissolution rate.
同时，使用FOCSDT人工神经网络法监测了甲硝唑维b 6片的体外溶出度。
At the same time, through FOCSDT artificial nerve network method have monitored dissolution of metronidazole and vitamin B6 tablets.
目的比较不同厂家、不同批次盐酸胺碘酮胶囊的体外溶出度，为其质量控制提供依据。
Objective To determine extracorporeal dissolution rate of national dragon's blood capsule, and to control its quality.
方法：采用液中干燥法制备穿心莲内酯微囊，并按《中国药典》方法测定体外溶出度。
Method: andrographolide microcapsules were prepared by a solvent evaporation technique, and the dissolution of andrographolide microcapsules was determined by the method of ChP.
方法采用分光光度法测定罗红霉素胶囊的体外溶出度，并对溶出参数进行相关性分析。
Methods The dissolution of roxithromycin capsules was analyzed with spectrophotometry. The dissolutive parameters of different products were compared.
本文用紫外分光光度法对9个厂家27个批号的阿斯匹林肠溶衣片和复方新诺明片进行了体外溶出度测定。
The dissolution of 27(?) lots of aspirin enteric-coated tablet and SMZ Co. Tabletmade by 9 factories was determined with ultraviolet spectrophotometry.
方法以不同分子量不同比例的聚乙二醇为载体，以熔融法制备固体分散体，并进行体外溶出度研究和DSC扫描。
METHODS Preparing the solid dispersion by melting method at different drug-to-PEG ratios with different PEG moleculars and studying the preparation with dissolution rate in vitro and DSC method.
方法将羧甲基淀粉钠、微晶纤微素按一定比例混合，作为片剂基本处方，以分散片的外观、崩解时限、体外溶出度及混悬性为指标进行处方筛选。
METHOD s Mixing the CMSNa and MCC in certain proportion as the basic formulation of the tablets, the appearance, disintegration, dissolution and the suspensibility were investigated.
方法将羧甲基淀粉钠、微晶纤微素按一定比例混合，作为片剂基本处方，以分散片的外观、崩解时限、体外溶出度及混悬性为指标进行处方筛选。
METHOD s Mixing the CMSNa and MCC in certain proportion as the basic formulation of the tablets, the appearance, disintegration, dissolution and the suspensibility were investigated.
应用推荐